Please use this identifier to cite or link to this item:
Title: Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell - mediated B-cell cytotoxicity
Authors: Mössner, E
Brünker, P
Moser, S
Püntener, U
Schmidt, C
Herter, S
Grau, R
Gerdes, C
Nopora, A
Van Puijenbroek E
Ferrara, C
Sondermann, P
Jäger, C
Klein, C
Umaña, P
Strein, P
Fertig, G
Friess, T
Schüll, C
Bauer, S
Dal Porto J
Del Nagro C
Dabbagh, K
Dyer, MJS
Poppema, S
First Published: 3-Jun-2010
Citation: BLOOD, 2010, 115 (22), pp. 4393-4402
DOI Link: 10.1182/blood-2009-06-225979
ISSN: 0006-4971
eISSN: 1528-0020
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Cancer Studies and Molecular Medicine

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.